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Abstract
Background: Bioelectrical Impedance (BIA) derived phase angle is increasingly being used as an
objective indicator of nutritional status in advanced cancer. Subjective Global Assessment (SGA) is
a subjective method of nutritional status. The objective of this study was to investigate the
association between BIA derived phase angle and SGA in advanced colorectal cancer.
Methods: We evaluated a case series of 73 stages III and IV colorectal cancer patients. Patients
were classified as either well-nourished or malnourished using the SGA. BIA was conducted on all
patients and phase angle was calculated. The correlation between phase angle and SGA was studied
using Spearman correlation coefficient. Receiver Operating Characteristic curves were estimated
using the non-parametric method to determine the optimal cut-off levels of phase angle.
Results: Well-nourished patients had a statistically significantly higher (p = 0.005) median phase
angle score (6.12) as compared to those who were malnourished (5.18). The Spearman rank
correlation coefficient between phase angle and SGA was found to be 0.33 (p = 0.004), suggesting
better nutritional status with higher phase angle scores.
A phase angle cut-off of 5.2 was 51.7% sensitive and 79.5% specific whereas a cut-off of 6.0 was
82.8% sensitive and 54.5% specific in detecting malnutrition. Interestingly, a phase angle cut-off of
5.9 demonstrated high diagnostic accuracy in males who had failed primary treatment for advanced
colorectal cancer.
Conclusion: Our study suggests that bioimpedance phase angle is a potential nutritional indicator
in advanced colorectal cancer. Further research is needed to elucidate the optimal cut-off levels of
phase angle that can be incorporated into the oncology clinic for better nutritional evaluation and
management.
Background
Bioelectrical Impedance Analysis (BIA) is an objective,
easy-to-use, quick, non-invasive, and reproducible tech-
nique to evaluate changes in body composition. BIA is
increasingly being used to assess nutritional status in
patients with cancer [1-7]. BIA measures body component
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resistance (R) and reactance (Xc) by recording a voltage
drop in applied current [8]. Reactance causes the current
to lag behind the voltage creating a phase shift. This shift
is quantified geometrically as the angular transformation
of the ratio of reactance to resistance, or the phase angle
[9].
Phase angle reflects the relative contributions of fluid
(resistance) and cellular membranes (reactance) of the
human body and has been suggested to be an indicator of
body cell mass and nutritional status [1]. By definition,
phase angle is positively associated with reactance and
negatively associated with resistance [9]. Lower phase
angles suggest cell death or decreased cell integrity, while
higher phase angles suggest large quantities of intact cell
membranes [10]. Phase angle has been found to be a
prognostic indicator in several clinical conditions such as
human immunodeficiency virus infection, liver cirrhosis,
chronic obstructive pulmonary disease, hemodialysis,
sepsis, lung cancer colorectal cancer, and pancreatic can-
cer [7,10-17]. For the lack of a well-agreed upon cut off
level for phase angle, previously published studies have
utilized either the mean or the median phase angle scores
of their respective patient populations to predict survival.
Although the cut-off levels for phase angle suggested by
the above studies seem to be in agreement with each
other, there is a clear need to define optimal thresholds of
phase angle as an indicator of nutritional status in
advanced cancer.
Subjective Global Assessment (SGA) is a subjective, sim-
ple, safe, inexpensive and effective method to assess nutri-
tional status in advanced cancer [1]. The SGA is a clinical
technique that combines data from subjective and objec-
tive aspects of medical history (weight change, dietary
intake change, gastrointestinal symptoms, and changes in
functional capacity) and physical examination (low levels
of subcutaneous fat and muscle mass, ankle or sacral
edema and ascites) [18]. After evaluation, patients are cat-
egorized into three distinct classes of nutritional status;
well-nourished (SGA A), moderately malnourished (SGA
B) and severely malnourished (SGA C). The SGA has been
extensively validated as a nutritional assessment tech-
nique in oncology patients [1,19,20].
The objective of this study was to investigate the associa-
tion between BIA derived phase angle (an objective
method of nutritional assessment) and SGA (a subjective
method of nutritional assessment) in advanced colorectal
cancer.
Methods
Patients
A retrospective chart review was performed on a consecu-
tive case series of 73 stages III and IV colorectal cancer
patients treated at Cancer Treatment Centers of America
(CTCA) at Midwestern Regional Medical Center (MRMC)
between January 2000 and March 2003. The patients were
identified from the MRMC tumor registry. All patients had
a histologically confirmed diagnosis of stages III and IV
colorectal cancer. All tumors were adenocarcinomas.
Tables 1 and 2 show the baseline characteristics of our
patient cohort. The study was approved by the Institu-
tional Review Board at Midwestern Regional Medical
Center.
Nutritional assessment
All patients underwent a baseline nutritional assessment,
which included SGA and BIA. SGA was performed by reg-
istered dietitians who reviewed the SGA instrument with
the patient to obtain answers to all the questions. The die-
titians also completed a physical exam paying particular
attention to low levels of subcutaneous fat and muscle
mass, presence of ankle and sacral edema and ascites.
After the consultation, the dietitians ranked the patient's
nutritional status as well-nourished (SGA A), moderately
malnourished (SGA B) or severely malnourished (SGA C).
For the purpose of this analysis, malnutrition was defined
as either SGA B or SGA C. BIA was performed using a Bio-
electrical Impedance Analyzer, Model BIA-101Q: RJL Sys-
tems, Clinton Township, MI, USA. BIA was conducted
while patients were lying supine on a bed or exam table,
with legs apart and arms not touching the torso. All eval-
uations were conducted on the patients' right side using
the four surface standard electrode (tetra polar) technique
on the hand and foot [21]. Resistance (R) and reactance
(Xc) were directly measured in Ohms at 50 kHz, 800 μA
using RJL BIA. One assessment of resistance (R) and reac-
tance (Xc) was made. Phase angle was calculated using the
following equation: Phase Angle = (Resistance/Reac-
tance)*(180/π).
Statistical analysis
All data were analyzed using SPSS 11.5 (SPSS Inc., Chi-
cago, IL, USA). For the purpose of this analysis, patients
were classified as either well-nourished (SGA-A) or mal-
nourished (SGA-B and SGA-C). The SGA-B and SGA-C
were merged together because of only 6 observations for
SGA-C. Phase angle was found to be nonnormally distrib-
uted as demonstrated by the Shapiro Wilk test statistic.
The median phase angle scores were compared across the
2 categories of nutritional status using non-parametric
Mann Whitney test. The correlation between phase angle
and SGA was studied using Spearman correlation coeffi-
cient owing to nonnormal distribution of phase angle.
Receiver Operating Characteristic (ROC) curves were esti-
mated using the non-parametric method [22,23] to fur-
ther evaluate the association between phase angle as an
indicator of nutritional assessment and SGA. The area
under the curve (AUC) was calculated to determine theNutrition Journal 2008, 7:19 http://www.nutritionj.com/content/7/1/19
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accuracy of phase angle as a nutritional assessment tool.
The further the curve lies above the reference line, the
more accurate the test. Coordinates of the curve were
examined across the full range of potential phase angle
cut-off values in an attempt to select an optimal phase
angle cut-off that properly balanced the needs of sensitiv-
ity and specificity. Since smaller values of phase angle are
believed to indicate worsening of nutritional status, sensi-
tivity was defined as the proportion of malnourished
patients with phase angle results smaller than the cut-off,
i.e. the ability of phase angle cut-off to estimate truly mal-
nourished patients. Similarly, specificity was defined as
the proportion of well-nourished patients with phase
angle results greater than equal to the cut-off, i.e. the abil-
ity of phase angle cut-off to estimate truly well-nourished
patients.
Results
Tables 1 and 2 show the baseline characteristics of our
patient sample.
The distribution of phase angle scores across the two
classes of nutritional status using non-parametric Mann
Whitney test found that well-nourished patients had a sta-
tistically significantly higher (p = 0.005) median phase
angle score (6.12) as compared to those who were mal-
nourished (5.18). The Spearman rank correlation coeffi-
cient between phase angle and SGA was found to be 0.33
(p = 0.004), suggesting better nutritional status with
higher phase angle scores.
Figure 1 shows the ROC curve for phase angle. The curve
reveals that phase angle provides modest diagnostic accu-
racy to distinguish between well-nourished and malnour-
ished status (AUC = 0.7; 95% CI = 0.57 to 0.82, p =
0.005). The sensitivities and specificities of potential
phase angle cut-offs, as suggested by the coordinates of
the curve data, are shown in Table 3. It was difficult to
identify an optimal cut-off level of phase angle with
simultaneously high levels of sensitivity and specificity.
The table suggests that the phase angle cut-off value of 5.7
combines modest levels of sensitivity (69%) with low lev-
A receiver operating characteristic curve assessing an opti- mal cut-off point of phase angle as a marker for malnutrition  as defined by the SGA (N = 73) Figure 1
A receiver operating characteristic curve assessing an opti-
mal cut-off point of phase angle as a marker for malnutrition 
as defined by the SGA (N = 73).
Table 2: Baseline Characteristics (N = 73)
Characteristic Mean Standard
Deviation
Range Normal
Values
Age at diagnosis (years) 56 11.4 29 – 82
Albumin (g/dl) 3.6 0.47 2.2 – 4.7 3.4 – 5.4
Phase Angle (degrees) 5.7 1.3 3.2 – 10.7 3 – 10
Prealbumin (mg/dl) 21.2 7.4 8.0 – 38 15.7 – 29.6
Transferrin (mg/dl) 244.7 57.3 76 – 397 250 – 300
g = grams
mg = milligrams
dl – deciliter
Table 1: Baseline Characteristics (N = 73)
Characteristic Number Percent (%)
Sex
Male 41 50.6
Female 40 49.4
Prior Treatment History
Progressive disease 42 51.9
Newly diagnosed 39 48.1
Tumor Stage at Diagnosis
Stage III 29 35.8
Stage IV 52 64.2
Tumor Grade at Diagnosis
Well 3 3.7
Moderate 56 69.1
Poor 18 22.2
Unknown 4 4.9
Subjective Global Assessment
Well-nourished 44 60.3
Malnourished
Moderately malnourished 23 31.5
Severely Malnourished 68 . 2Nutrition Journal 2008, 7:19 http://www.nutritionj.com/content/7/1/19
Page 4 of 6
(page number not for citation purposes)
els of specificity (56.8%). Increasing the phase angle cut-
off to 6.0 raises the sensitivity level to 82.8% without
much loss in the level of specificity (54.5%). This implies
that using a cut-off level of 6.0 for phase angle, 82.8% of
truly malnourished patients will be correctly identified as
malnourished, whereas 45.5% (1-specificity) of truly
well-nourished patients will be incorrectly identified as
malnourished. On the other hand, using 5.2 as the cut-off
value for phase angle, only 51.7% of truly malnourished
patients will be correctly identified as malnourished,
whereas 20.5% (1-specificity) of truly well-nourished
patients will be incorrectly identified as malnourished.
In order to examine the differences due to gender and
prior treatment history, separate ROC curves were con-
structed for males, females, newly diagnosed patients and
patients with prior treatment history. ROC curves were
also constructed for different combinations of gender and
prior treatment history. The area under the curve, optimal
phase angle cut-off levels, and the corresponding sensitiv-
ities and specificities for all patient subgroups are dis-
played in Table 4. The only patient subgroup for which
high levels of both sensitivity and specificity could be
obtained was males with progressive disease. In this
patient subgroup, a phase angle cut-off level of 5.9 was
100% sensitive and 73.3% specific in diagnosing malnu-
trition. Figure 2 shows the ROC curve for phase angle in
this patient subgroup.
Discussion
Although BIA derived phase angle has been used as a com-
plementary nutritional assessment tool in cancer, we need
to be able to choose a specific cut-off level that can help
the treating oncologists and clinical nutritionists classify
cancer patients as either well-nourished or malnourished.
The choice of the cutoff is mandated by the need to closely
match the sensitivity and specificity of the traditional
nutritional tests. One way of achieving this goal is to eval-
uate phase angle against a test that has been extensively
validated in similar treatment settings. This study was
undertaken to investigate the association between BIA
derived phase angle as an indicator of nutritional status,
and SGA in advanced colorectal cancer.
The sensitivities and specificities considered together for
potential optimal cut-off levels of phase angle were found
to be modest at best and the test was found to be either
too sensitive or too specific. We found that using different
cut-off levels for males versus females, and for newly diag-
nosed patients versus those with progressive disease might
be more appropriate as opposed to using single cut-off
level for all patients. Interestingly, a phase angle cut-off of
5.9 demonstrated high diagnostic accuracy in males who
had failed primary treatment for advanced colorectal can-
cer. Our findings are consistent with those reported by
another group of researchers who evaluated phase angle
against SGA in 279 patients undergoing elective gastroin-
testinal surgery [1]. The study found a fair overall agree-
ment between SGA and BIA estimates and couldn't obtain
an optimal phase angle cut-off with high sensitivity and
specificity. The study also suggested different potential
cut-offs for men (6.3) and women (5.9) indicating a better
balance of sensitivity and specificity. A study conducted in
patients with advanced lung cancer stratified the patient
cohort by the mean phase angle score of 4.5. Interestingly,
patients with phase angle scores less than or equal to 4.5
had a significantly shorter survival than those with phase
angle scores greater than 4.5 [7]. Another study conducted
in HIV-infected patients stratified patients into 4 quartiles,
with 5.3, 5.9 and 6.5 as the cut-off points. The study found
phase angle to be an independent prognostic marker of
A receiver operating characteristic curve assessing an opti- mal cut-off point of phase angle as a marker for malnutrition  as defined by the SGA in males with progressive colorectal  cancer (N = 18) Figure 2
A receiver operating characteristic curve assessing an opti-
mal cut-off point of phase angle as a marker for malnutrition 
as defined by the SGA in males with progressive colorectal 
cancer (N = 18).
Table 3: Sensitivities and specificities of selected phase angle cut-
off levels (N = 73)
Phase Angle Cut-off Sensitivity (%) Specificity (%)
5.2 51.7 79.5
5.3 55.2 68.2
5.4 58.6 65.9
5.7 69.0 56.8
6.0 82.8 54.5Nutrition Journal 2008, 7:19 http://www.nutritionj.com/content/7/1/19
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clinical progression and survival [17]. In another prospec-
tive study of liver cirrhosis patients, phase angle equal to
or less than 5.4 was associated with shorter survival as
compared to phase angle greater than 5.4 [10].
In our study, no optimal phase angle cut-off level with
simultaneously high levels of sensitivity and specificity
could be identified. There are several potential explana-
tions of these findings. 1. BIA derived phase angle is not a
valid indicator of nutritional status in advanced cancer, 2.
Phase angle and SGA capture different aspects of nutri-
tional status and might complement each other in overall
nutritional evaluation, 3. Phase angle is a valid marker of
nutritional status and the relatively modest correlations
observed in the present study might be escalated using a
larger sample size. In the present study a phase angle cut-
off level of 5.2 had low sensitivity but high specificity
whereas a cut-off level of 6.0 had high sensitivity but low
specificity. It is likely that an optimal phase angle cut-off
level is located somewhere between these two values. We
believe that the goal of achieving an optimal phase angle
cut-off with high levels of sensitivity and specificity
should be further explored in similar patient populations
with larger sample sizes.
ROC analysis at best provides guidelines for which cut-
offs should be considered. We believe that the choice of
an optimal cut-off level for any diagnostic test is context
dependent. In our study, we evaluated the optimal cut-off
levels of phase angle as a nutritional assessment tool in
advanced colorectal cancer. Since malnutrition is a major
cause of morbidity and mortality in these patients, the
treating oncologists and clinical nutritionists might find it
more worthwhile to be able to correctly identify a high
proportion of malnourished patients (a high sensitivity)
even though it comes at the expense of reduced specificity
(a high rate of false positives). In such situations, selecting
a high cut-off level of 6 makes more sense as opposed to
selecting a low cut-off level of 5.2.
What exactly is phase angle? Some earlier studies have
tried to address these questions, albeit in a limited capac-
ity. For instance, Schwenk et al. hypothesized that phase
angle could possibly be interpreted as a global marker of
malnutrition in HIV infected patients [17]. In another
study conducted on HIV-infected patients, it was argued
that phase angle reflects the integrity of vital cell mem-
branes [15]. In patients with liver cirrhosis, phase angle
was speculated to be a marker of clinically relevant malnu-
trition characterized by both increased extracellular mass
and decreased body cellular mass [10]. In advanced lung
cancer, phase angle was speculated to be an indicator of
altered tissue electrical properties [7].
Limitations of this study relate to the BIA technique, ret-
rospective study design and small sample size. This study,
because of its retrospective nature, relies on data not pri-
marily meant for research. The subgroup ROC analyses
were based on small sample sizes without accounting for
the number of multiple comparisons made in this study.
The non-normal distribution of phase angle in our study
could be an effect of the small sample size. Despite these
limitations, our study provides valuable insights on what
might be an appropriate phase angle cut-of level in
patients with advanced colorectal cancer. Clearly, there is
a need to validate the diagnostic accuracy of phase angle
using larger sample sizes in advanced cancer populations.
It has been suggested that the variability of direct bioim-
pedance measures (resistance, reactance, and phase angle)
depends on age, gender, and body mass characteristics of
the study population which could possibly limit the
extrapolation of the model [24,25]. Some other reported
limitations of using BIA for assessment of body composi-
tion are hydration status and/or major disturbances of
water distribution, body position during procedure,
ambient air and skin temperatures, recent physical activ-
ity, conductance of the examining table, abstinence from
alcohol and caffeinated beverages, food consumption and
voiding 30 minutes prior to measurement [26]. Since the
original intent of the BIA in this study was to gather esti-
mates of body composition as part of a baseline nutri-
tional assessment in a clinical setting, not all of these
factors could realistically be controlled. Patients were free
Table 4: Receiver Operating Characteristic analysis based on gender and prior treatment history
Patient Subgroup N AUC
(95% CI)
Cut-off
level
Sensitivity
(%)
Specificity
(%)
Males 38 0.67 (0.48 – 0.85) 6.0 73.3 65.2
Females 35 0.75 (0.58 – 0.92) 5.6 71.4 47.6
Newly Diagnosed 33 0.64 (0.45 – 0.83) 6.0 72.2 46.7
Progressive Disease 40 0.79 (0.65 – 0.93) 5.6 81.8 62.1
Males with Progressive Disease 18 0.87 (0.69 – 1.0) 5.9 100 73.3
Females with Progressive Disease 22 0.72 (0.50 – 0.95) 6.0 100 42.9
N = Sample Size
AUC = Area Under the Curve
CI = Confidence IntervalNutrition Journal 2008, 7:19 http://www.nutritionj.com/content/7/1/19
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of visible edema or ascites so there was control for obvi-
ous overhydration. However, it is to be noted that hydra-
tion status in cancer patients are often due to treatment,
therefore, just observing obvious signs of hydration may
have overlooked changes that could further have influ-
enced measurement validity. Body position was control-
led for because all patients were in the supine position in
a bed or on an exam table. Air temperature was within a
controlled range in our hospital setting. Physical activity
was limited in these patients due to the advanced nature
of their disease. Food intake was not controlled for in this
clinical setting, which may have contributed to a small
amount of variability. No assessment of inter-rater relia-
bility of the users of BIA and SGA was made in this study.
This bias, however, was minimized by restricting the use
of BIA and SGA to well-trained dietitians with an expertise
in the use of these clinical techniques. Moreover, BIA was
conducted in all patients using the same analyzer. Finally,
we believe that future studies should use a more objective
method of nutritional assessment in order to derive the
definitive cut-offs of phase angle.
Conclusion
In summary, our study suggests that bioimpedance phase
angle is a potential indicator of nutritional status in
advanced colorectal cancer. Further research is needed to
elucidate the optimal cut-off levels of phase angle that can
be incorporated into the oncology clinic for better nutri-
tional evaluation and management.
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